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The antineoplastic drug cisplatin promotes renal injury, which limits its use. Protocols that
reduce renal cisplatin toxicity will allow higher doses to be used in cisplatin treatment.
Here, we compare physical exercise and caloric restriction (CR) as protocols to reduce
cisplatin renal injury in mice. Male C57BL/6 were divided into four groups: Control,
cisplatin, exercise + cisplatin, and 30% CR + cisplatin. Animals were injected with a
single dose of cisplatin (20mg/kg i.p.) and sacrificed 96 h after injection. Quantitative real
time PCR, histological analyses, immunohistochemistry, and biochemical measurements
were performed to investigate renal injury, necrosis, apoptosis, and inflammatory
mechanisms. Both protocols protected against cisplatin renal injury, but CR was more
effective in reducing uraemia and renal necrosis. The CR + Cisplatin group exhibited
reduced serum IL-1β and TNF-α levels. No differences were noted in the renal mRNA
expression of cytokines. Both interventions reduced apoptosis, but only the CR +
Cisplatin group decreased TNFR2 protein expression. PPAR-α was activated in mice
after CR. An antagonist of PPAR-α blocked the protective effect of CR. Both interventions
attenuated the nephrotoxicity caused by cisplatin injection, but CR + Cisplatin showed
a better response by modulating TNFR2. Moreover, part of the CR benefit depends on
PPAR-α activation.
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INTRODUCTION
Cisplatin is an antineoplastic drug used to treat multiple cancers, including those of the head, neck,
lungs, testicles, breast, and ovaries. Cisplatin may induce ototoxicity, gastrotoxicity, hepatotoxicity,
neurotoxicity, myelosuppression, and allergic reactions, but the main side effect is nephrotoxicity.
Between 20 and 30% of the patients treated with cisplatin experience acute kidney injury (Miller
et al., 2010). The mechanisms of cisplatin nephrotoxicity involve oxidative stress, apoptosis,
inflammation, and fibrinogenesis. In addition, high cisplatin concentrations induce proximal
tubule cell necrosis (Lieberthal et al., 1996).
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Tumor necrosis factor receptor 2 (TNFR2) is important
in cisplatin-induced acute kidney injury. Knockout mice
for this receptor exhibit attenuated side effects of cisplatin
nephrotoxicity, including diminished acute tubular necrosis,
lowered pro-inflammatory cytokine expression, and diminished
leukocyte infiltration and apoptosis (Ramesh and Reeves, 2003).
Physical exercise can alter the immune system, affecting innate
immune response cells, such as neutrophils, macrophages and
NK cells, the humoral system (antibodies and cytokines), and
acute phase proteins (Nieman and Nehlsen-Cannarella, 1994;
Pedersen et al., 2003; Wasinski et al., 2013).
Recently, physical exercise was shown to diminish cisplatin-
induced acute kidney injury by promoting interleukin-6
and heme oxygenase-1 expression in the kidney, decreasing
inflammation and cell death (Miyagi et al., 2014).
Caloric restriction (CR) includes a wide variety of
interventions that result in nutrient reduction and energy
consumption without causing desnutrition. CR augments life
expectancy and resistance to multiple forms of acute stress
by controlling inflammation, oxidative stress and apoptosis
(Sinclair, 2005; Brown-Borg, 2006; Bishop and Guarente, 2007).
Moreover, CR reduces the damage caused by ischaemia and
reperfusion in the heart, brain and kidney (Yu and Mattson,
1999; Chandrasekar et al., 2001; Ahmet et al., 2005; Mitchell
et al., 2010), ameliorates insulin sensitivity, augments antioxidant
proteins and diminishes inflammatory markers such insulin
grown factor-1 signaling (Mitchell et al., 2010).
Knowing that inflammation is a key factor in cisplatin
nephrotoxicity and that CR and exercise are two non-
pharmacological interventions to attenuate inflammation, we
decided to compare the roles of both interventions in cisplatin-
induced acute kidney injury.
MATERIALS AND METHODS
Animals
Male C57BL/6mice weighing 25–30 g and of 12 weeks of age were
used for these experiments. Single doses of cisplatin (20 mg/kg;
Bergamo, Taboão da Serra, Brazil) were injected intraperitoneally
(i.p.), and the animals were sacrificed 96 h after the injection.
The animals were obtained from the Animal Care Facility at the
Federal University of São Paulo (UNIFESP). All animals were
housed individually in standard cages and had free access to water
and food. All procedures were previously reviewed and approved
by the internal ethical committee of the institution (Figure 1).
Experimental Design
Mice (n = 6 per group) were divided in four different groups:
(1) control mice (Control), (2) cisplatin-treated mice (CIS), (3)
exercise + cisplatin-treated mice (EX + CIS), and (4) 30% CR +
cisplatin-treated mice (CR+ CIS).
CR Protocol
The amount of food eaten ad libitumwas determined byweighing
the remaining food on a daily basis for 1 week. CRwas applied for
4 weeks by feeding mice 70% of this amount on a daily basis.
Exercise Protocol
The animals were subjected to swimming sessions in a swimming
system adapted for mice with water heated to 30◦C. The
swimming sessions began with 15min in the first week and
gradually increased in length until the mice were able to swim for
60min a day. After the adaptation period (2 weeks), mice were
subjected to 5 swimming sessions per week for 4 weeks.
Renal Function
Serum creatinine and urea levels were used to determine renal
function. Blood was collected by heart puncture. All samples were
analyzed with colorimetric assays, using commercial kits to detect
creatinine and urea (both from Labtest, Lagoa Santa, Brazil).
Quantification of Gene Expression
Kidney samples were frozen at −80◦C. Total RNA was
isolated using TRIzol reagent according to the manufacturer’s
instructions (Invitrogen, Carlsbad, CA). First-strand cDNA
was synthesized using the High Capacity cDNA Reverse
Transcription kit (Applied Biosystems). Real-time PCR was
performed using two systems: The TaqMan system (Applied
Biosystems, Carlsbad, CA) using probes for IL-6 (mm00446190-
m1), TNF-α (mm00443258-m1), and GAPDH (mm99999915-
g1), and the SYBR Green assay (Thermo Scientific, Waltham,
MA) using the primers described in Table 1. The cycling
conditions for both the TaqMan and SYBR Green primers were
as follows: 10 min at 95◦C, followed by 45 cycles of 30 s at 95◦C,
30 s at 60◦C, and 30 s at 72◦C. Standard curves were performed
for each primer pair to check the amplification efficiency. Target
mRNA expression was normalized to β-actin for SYBR and to
GAPDH for TaqMan and expressed as a relative value using the
comparative threshold cycle (Ct) method (2−11Ct) according
to the manufacturer’s instructions. The expression levels of the
genes of interest were normalized to the control group. All
samples were run in duplicates.
Histological Analyses
Formaldehyde-fixed paraffin sections of kidneys were stained
with haematoxylin and eosin (H&E). Optic light microscopy
was employed to analyse the samples. Images were acquired
at ×40 magnification. Epithelial desquamation, cellular debris,
flattening of the epithelium, presence of cylinders, and dilation
of the tubular lumen were used as criteria for tubular injury. The
injuries were graded using a scoring procedure, in which I = 0–
10% of the total kidney area was compromised, II= 11–25, III=
26–50, and IV ≥ 50%.
Immunohistochemistry
Localization of cleaved caspase-3 was assessed in paraffin-
embedded tissue sections. As described previously, the slides
were deparaffinised and rehydrated. Antigens were retrieved
in a citrate buffer solution (pH 6) at 95◦C. The endogenous
peroxidase activity was blocked with 3% hydrogen peroxide
solution, and the sections were additionally blocked with Protein
Block Solution (DAKO, Glostrup, Denmark). The slides were
incubated with the primary antibody (diluted 1:1,000, Cell
Signaling Technologies, Beverly, MA) or isotype non-specific
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FIGURE 1 | Drug treatment scheme. Mice were submitted to exercise or
caloric restriction for 4 weeks prior to cisplatin injection (A). Mice were treated
with MK886 24 h prior to initiate caloric restriction. Treatment with MK886
were kept into the day of sacrifice. Cisplatin was administrated in the end of
the 4th week of caloric restriction and mice were sacrificed 96 h after the
injection (B). n = 6 per group.
IgG as a negative control, followed by incubation with the
labeled EnVision polymer (DAKO, Glostrup, Denmark) using
two sequential 30 min incubations at room temperature. The
staining was developed by incubating for 1–3 min with 3,39-
diaminobenzidine plus substrate chromogen, which stains the
specific antigen brown. Haematoxylin counterstaining was also
performed.
Analysis of Cytokines in Serum
Serum samples were stored at −80◦C. The panel used
for the Bio-plex Mouse cytokine/chemokine assay (Bio-
Rad, Hercules, CA) included the following cytokines:
MCP-1, TNF-α, IL1-β, IL-6, and IL-10. Testing was
conducted in accordance with the procedures previously
described by the manufacturer. All the samples were run in
duplicates.
Enzyme-Linked Immunosorbent Assay
Kidney samples were stored at −80◦C. Protein was
extracted with RIPA Buffer. Kidney TNF receptor levels
were quantified using Quantikine ELISA mouse TNFR1
and mouse TNFR2 (R&D Systems, Minneapolis, MN),
respectively, according to the instructions provided
by the manufacturer. All the samples were run in
duplicates.
TABLE 1 | Base pair sequences of primers used in real-time PCR assays.
Gene Primers
β-actin 5′-CTGGCCTCACTGTCCACCTT-3′
5′-CGGACTCATCGTACTCCTGCTT-3′
IL-1β 5′-AGGAGAACCAAGCAACGACA-3′
5′-CGTTTTTCCATCTTCTTCTTTG-3′
BAX 5′-CGGCGAATTGGAGATGAACTG-3′
5′-GCAAAGTAGAAGAGGGCAACC-3′
BCL-2 5′-ACCGTCGTGACTTCGCAGAG-3′
5′-GGTGTGCAGATGCCGGTTCA-3′
TNFR1 5′-TACATCCATCAGGGGTCACT-3′
5′-AGGCACAACTTCATACACTC-3′
TNFR2 5′-GTCGCGCTGGTCTTCGAACTG-3′
5′-GGTATACATGCTTGCCTCACAGTC-3′
CPT-1A 5′-GTTCCCCGCGAGTCCCTCCA-3′
5′-GCTTGACATGCGGCCAGTGGT-3′
CPT-2 5′-CCAAGCACAGTGTGGGCGAGC-3′
5′-GGTCAAAGCCCTGGCCCATCG-3′
CYP4A 5′-GGAGGATGCTAACCCCAGCCTTCC-3′
5′-GCCAGCCGTTCCCATTTGTCTAGC-3′
PPAR-α 5′-ATGCCAGTACTGCCGTTTTC-3′
5′-TTGCCCAGAGATTTGAGGTC-3′
IL-1β, interleukin 1β; BAX, Bcl-2-associated X; BCL-2, B-cell lymphoma 2; TNFR1, tumor
necrosis factor receptor 1. TNFR2, tumor necrosis factor receptor 2; CPT-1A, carnitine
palmitoyltransferase 1A; CPT-2, carnitine palmitoyltransferase 2; CYP4A, cytochrome
P450 4A; PPAR-α, peroxisome proliferator-activated receptor alpha.
Western Blotting
For each kidney sample total protein was isolated using RIPA
buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-
40, 1% sodium deoxycholate, 0.1% SDS) and global protein
was measurement by BCATM Protein Assay Kit (Pierce,
EUA). Around 50 µg of tissue protein was utilized for SDS-
PAGE electrophoresis on 12.5% polyacrylamide gels. The
immunostaining was performed with primary antibodies
(Anti-Cofilin/1:1,000, Abcam, USA, Anti-PPAR-α/1:300,
Abcam, Anti-CPT1A/1:1,000, Abcam, Anti-CPT-2/1:500,
Abcam and Anti-Beta Actin/1:5,000, Cell Signaling, USA),
followed by conjugated secondary antibodies (anti-mouse
or anti-rabbit peroxidase/1:250.000, Sigma, USA). After, the
nitrocellulose membrane was revealed by chemiluminescence
methods using the ECL kit (Millipore, USA), and the
images were acquired on Amersham Imager 600 equipment
(GE Healthcare, UK). The SyncMaster 740 n software
device (GE Healthcare, UK) were used to analyze and
quantify the gel bands. The experiment was reapeated
twice.
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FIGURE 2 | Renal function and ATN score. Serum creatinine is reduced in both the CR+CIS and EX+CIS groups compared with the animals that received only
cisplatin (A). Urea is reduced only in the CR+CIS group (B). The CR+CIS group presented a better score in the ATN test, showing less necrosis in renal tissue. CIS,
cisplatin; EX+CIS, exercise + cisplatin; CR+CIS, caloric restriction + cisplatin; *p < 0.05. n = 6.
FIGURE 3 | Body weight and food intake. (A) Changes in body weight and (B) food intake after cisplatin injection. CIS, cisplatin; EX+CIS, exercise + cisplatin;
CR+CIS, caloric restriction + cisplatin. *p < 0.05. n = 6.
PPAR-Alpha Antagonist Treatment
Male C57BL/6 mice weighing 25–30 g and 12 weeks of age were
injected i.p. with 3 mg/kg of MK886 (Cayman Chemicals, Ann
Arbor, MI) 1 day prior to beginning CR and received one dose
daily until the day of sacrifice (Figure 1).
Statistical Analysis
All data are presented as the mean ± s.e.m. Different results
between the groups were compared using analysis of variance
(one-way ANOVA). The value for statistical significance was
established at P < 0.05. All statistical analyses were performed
using GraphPad Prism (GraphPad, La Jolla, CA), all the
other comparisons without the presence of brackets were not
significant.
RESULTS
Exercise and CR Ameliorate Cisplatin
Renal Injury
It was previously shown that 7 weeks of chronic exercise on a
training treadmill protected mice from cisplatin-induced renal
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FIGURE 4 | Serum cytokines. Serum leveols of (A) IL-1β, (B) IL-6, (C), IL-10, (D) MCP-1, and (E) TNF-α. CIS, cisplatin; EX+CIS, exercise + cisplatin; CR+CIS,
caloric restriction + cisplatin. *p < 0.05. n = 5–6.
FIGURE 5 | Renal mRNA expression of cytokines. The EX+CIS and CR+CIS groups exhibited reduced (A) IL-1β, (B) TNF-α, and (C) IL-6 mRNA expression in the
kidney compared to the CIS group, but there were no local differences between the expression of these genes in the CR+CIS and EX+CIS group kidneys. CIS,
cisplatin; EX+CIS, exercise + cisplatin; CR+CIS, caloric restriction + cisplatin. *p < 0.05. n = 5–6.
injury (Miyagi et al., 2014). Here, we show the effects from CR
and swimming exercise. Figure 2A shows the reduced serum
creatinine levels in both the CR+CIS and EX+CIS groups
compared with the animals that received only cisplatin. However,
the serum urea levels were only reduced in the CR+CIS group
(Figure 2B). The histology analyses showed that CR completely
protected the kidney from tubular necrosis induced by cisplatin,
and exercise was not as effective (Figure 2C). These results
suggest different mechanisms of protection for CR and exercise.
Figure 3 shows the reduced effect on body weight loss and
changes in food intake in both the CR+CIS and EX+CIS groups
when compared to animals treated with only cisplatin.
Serum IL-1β and TNF-α Are Reduced in the
CR+CIS Group
To identify the differentmechanisms of kidney protection against
cisplatin treatment for CR and exercise, we measured cytokine
levels in mouse serum. The levels of IL-1β and TNF-α were
lower in the CR+CIS group than in the EX+CIS group. We did
not see significant differences between IL-6, MCP-1, and IL-10
expression in the CR+CIS and EX+CIS groups (Figure 4).
The Local Cytokine Formation Is Similar in
Kidneys from Both Treatment Groups
The differences in IL-1β and TNF-α serum levels were not
explained by local kidney production of these cytokines, at least
at the mRNA expression level. Both the CR+CIS and EX+CIS
groups exhibited similar mRNA expression of both cytokines
(Figure 5).
Both Interventions Reduced Apoptosis,
But Only the CR+CIS Group decreased
TNFR2 Protein Expression
Because the CR+CIS group exhibited reduced tubular necrosis
compared to the EX+CIS group, we checked the expression of
genes related to apoptosis (Figures 6A–C). The CR+CIS and
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FIGURE 6 | Protein and mRNA expression of apoptotic factors. Although the Bax/Bcl-2 ratio is similar in the CR+CIS and EX+CIS groups, TNFR2 protein
expression was reduced in the CR+CIS group compared to the CIS and EX+CIS groups. (A,B,D,E) mRNA expression and renal protein assay of TNFR1 and TNFR2
by ELISA. (C) Bax/Bcl-2 ratio. (F) Cleaved caspase-3 present in kidney tissues. The section images illustrate the result in panel (F). CIS, cisplatin; EX+CIS, exercise +
cisplatin; CR+CIS, caloric restriction + cisplatin. * p < 0.05. n = 5–6.
EX+CIS groups had similar apoptosis activation, as shown by
the similar Bax/Bcl-2 ratios in Figure 6C. On the other hand,
TNFR2 protein expression was reduced in the CR+CIS group
compared to the EX+CIS group (Figure 6E). Cleaved caspase-
3, one of the main effectors of apoptosis, was also reduced
in the CR+CIS group compared with the EX+CIS group, as
analyzed by immunohistochemistry (Figure 6F). Together with
the reduced necrosis shown in Figure 2C, these results suggest
a different mechanism for CR protection against cisplatin renal
injury. No significant difference where observed in TNFR-1
(Figure 6D).
CR Up-Regulates mRNA Expression of
PPAR-Alpha and Its Targets Genes in
Kidneys
We measured the mRNA expression of PPAR-α and its target
genes in animals that underwent exercise and CR without
cisplatin injection. The mRNA expression of PPAR-α and its
targets genes were increased in the CR group (Figures 7A–D).
PPAR-α activates lipid oxidation via the activation of acyl-
CoA oxidase, the first enzyme in the beta-oxidation pathway.
The activation of PPAR-α may be involved in the mechanism
underlying the better renal protection against cisplatin injury
observed in mice treated previously with CR.
CR and Exercise Increases PPAR-Alpha
Expression but Only CR Up-Regulates
CPT-1A and CPT-2 in Renal Tissue
We performed western blotting to assay the expression of PPAR-
α, CPT-1A andCPT-2,(two target proteins of PPAR-α activation).
The protein expression of PPAR-α were increased in the CR and
exercised group (Figure 8A), however only CR was capable to
increase CPT-1A and CPT-2 expression (Figures 8B,C).
An Antagonist of PPAR-α Blocks the
Protective Effect of CR in Urea and
Necrosis in Cisplatin-Treated Mice
To test if PPAR-α is involved in the CR mechanism of renal
protection from cisplatin nephrotoxicity, we treated mice on
CR with MK886, a PPAR-α antagonist (Kehrer et al., 2001),
and compared these mice with the CIS and control groups.
Mice on CR and treated with this PPAR-α antagonist and
cisplatin presented similar increases in serum urea levels as
animals treated only with cisplatin, when compared to the control
group (Figure 9A). The same effect was not observed for the
serum creatinine levels (Figure 9B). Moreover, the acute tubular
necrosis score was not completely reduced in the CR group
treated with MK886 (Figure 9C).
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FIGURE 7 | PPAR-alpha and its target genes profile expression in the kidney. CPTs and CYP4A are targets of PPAR-alpha activation, CPTs acts in Beta
oxidation of long chain fatty acids while CYP4A participates in omega hydroxilation of medium chain fatty acids. Renal mRNA expression of (A) PPAR-alpha, (B)
CPT-1A, (C) CPT-2, and (D) CYP4A in the kidneys of animals without cisplatin injection. CR activates PPAR-a target genes. EX, physical exercise; CR, caloric
restriction. *p < 0.05. n = 5–6.
PPAR-α Antagonism Blocks the Beneficial
Effect of CR on Apoptosis, Bax/Bcl2 Ratio,
and Renal mRNA Expression of TNF-α
We assessed the changes in renal mRNA expression in the
animals on CR and treated with MK886. The cisplatin effect
on TNFR2, IL-1b, and IL-6 mRNA expression was not changed
by blocking PPAR-α (Figures 10A,D,E), but the beneficial effect
observed on the Bax/Bcl2 ratio and TNF-α was clearly blocked
(Figures 10B,C). These results can be compared to those in
Figures 4, 5, where the effect of CR on the mRNA expression of
these factors was markedly stronger.
DISCUSSION
Cisplatin is a widely used drug for various tumors. However,
its deleterious side effects in the kidney limit its therapeutic use
(Arany and Safirstein, 2003; Miller et al., 2010). Inflammation
and apoptosis are involved in triggering the nephrotoxicity
caused by cisplatin (Yao et al., 2007; Miller et al., 2010).
Both physical exercise and caloric restriction (CR) are non-
pharmacological interventions to mitigate the inflammatory
effects of diseases such as obesity (Ahmed et al., 2009; Wasinski
et al., 2013), diabetes (Solomon et al., 2008; Snel et al., 2011,
2012), cardiovascular diseases (Chandrasekar et al., 2001; Ahmet
et al., 2005; Edwards et al., 2010), and kidney diseases (Friend
et al., 1978; Kobayashi and Venkatachalam, 1992; Cherry et al.,
1998; Mitchell et al., 2010; Miyagi et al., 2014). In this study, we
show that both exercise and CR attenuate the acute renal failure
induced by cisplatin, but CR has a stronger effect than exercise.
For the molecular mechanism of this protection, we hypothesize
that CR modulates PPAR-α activation.
The stronger effect of CR compared to exercise was observed
in its effect on mitigating weight loss. Moreover, animals
subjected to CR did not exhibit a sharp drop in food intake.
We also observed that physical exercise and CR normalized
creatinine levels, but only CR reduced the urea levels after
exposure to cisplatin. Together with the evaluation of acute
tubular necrosis, where we observed better protection in the
group of animals subjected to CR, this finding confirms the
stronger effect of CR in protecting against cisplatin renal injury
compared to the physical exercise protocol.
TNF-α is the main cytokine involved in acute kidney injury
induced by cisplatin (Ramesh and Reeves, 2002; Pabla and Dong,
2008). TNF-α knockout mice showed a better response when
treated with cisplatin, including better renal function, reduced
inflammation and lower levels of necrosis (Ramesh and Reeves,
2002). Knowing that both circulating and tissue cytokines are
important in triggering acute kidney injury induced by cisplatin
(Arany and Safirstein, 2003; Yao et al., 2007; Miller et al., 2010),
Frontiers in Physiology | www.frontiersin.org 7 March 2017 | Volume 8 | Article 116
Estrela et al. CR Attenuates Nephrotoxicity via PPAR-Alpha
FIGURE 8 | PPAR-alpha and its target genes protein expression in the kidney. Renal protein expression of (A) PPAR-alpha, (B) CPT-1a, and (C) CPT-2 in the
kidneys of animals without cisplatin injection. Protein expression performed by western blotting. EX, physical exercise; CR, caloric restriction. *p < 0.05. n = 5.
we analyzed serum levels and tissue expression of the main
cytokines and observed lower serum levels of TNF-α and IL-1β in
the CR group than in exercise group. As we found no differences
between physical exercise and CR for either IL-6, MCP-1, and IL-
10 serum levels or mRNA expression in renal tissue, we conclude
that the differences between the treatments came from another
mechanism.
We did not see a significant difference in TNFR2 mRNA
expression, only a downward trend in the CR group. Because
small changes in mRNA expression can lead to large changes
in protein levels, we analyzed TNFR2 protein expression
by ELISA and found reduced expression of this receptor
in the CR group. Moreover, we analyzed cleaved caspase-
3 by immunohistochemistry and showed that CR provides
greater protection than exercise against apoptosis. Our results
corroborate with the literature, as the role of TNFR2 in the
control of apoptosis and necrosis in cisplatin nephrotoxicity
is well-described (Ramesh and Reeves, 2003; Pabla and Dong,
2008; Miller et al., 2010). TNFR2 has an essential role in
controlling apoptosis and necrosis, and this receptor is more
important than TNFR1 in mediating key events triggered
by cisplatin nephrotoxicity, including necrosis, apoptosis and
inflammation (Ramesh and Reeves, 2003). A previous report
shows that mice with a deletion in this gene that were
exposed to cisplatin exhibited improved renal function, reduced
necrosis, lower levels of apoptosis and less inflammation
compared to TNFR1 knockout mice and wild-type mice
Apoptosis occurs by both the intrinsic pathway and extrinsic
pathway in cisplatin nephrotoxicity (Pabla and Dong, 2008;
Miller et al., 2010). We observed that both exercise and
CR decreased the Bax/Bcl-2 gene expression ratio, suggesting
a lower activation of apoptosis via the intrinsic pathway.
However, physical exercise does not decrease TNFR2 expression,
resulting in greater overall apoptosis and reduced protection
from tubular necrosis compared to the CR group. From the
data presented here, we showed that the main difference
between the two interventions is that CR can modulate TNFR2,
resulting in a better response to cisplatin-induced acute renal
injury.
Knowing that both exercise and CR modulate PPAR-α
(Iemitsu et al., 2002; Corton et al., 2004; Zhang et al., 2011;
Lempiäinen et al., 2013), we analyzed the expression of PPAR-α
and its target genes. PPAR-α is well-known as a nuclear sensor
controlling lipid metabolism mainly in the liver and kidneys
(Braissant et al., 1996). Deletion of this gene causes deterioration
in models of acute renal failure induced by cisplatin or ischaemia
and reperfusion. Treatment with activators of PPAR-α, such
as fibrates, can mitigate the deleterious effects of cisplatin and
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FIGURE 9 | Effect of PPAR-α antagonism on markers for renal injury in mice on CR and cisplatin treatment. Serum levels of (A) Urea, and (B) creatinine,
histological analysis of (C) acute tubular necrosis score. *p < 0.05. n = 5–6.
FIGURE 10 | Effect of PPAR-α antagonism on mRNA expression of apoptosis-related genes and cytokines in the kidneys of mice on CR and cisplatin
treatment. (A) TNFR2, (B) Bax/Bcl2 ratio, (C) TNF-alpha, (D) IL-1b, and (D) IL-6 renal mRNA expression. *p < 0.05. n = 5–6.
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ischaemia and reperfusion (Li et al., 2004a,b, 2005). Animals
subjected to CR and exercise showed increased PPAR-α protein
expression, in the other hand only CR were capable to increase
mRNA and protein levels of PPAR-α target genes. Like other
nuclear hormone receptors, PPAR acts as a ligand-activated
transcription factor. PPAR-α, when activated after binding
with specific ligand, interacts with RXR and regulates the
expression of target genes (Cuzzocrea, 2006). Furthermore, a
PPAR-α antagonist partially removed the benefits caused by CR.
Urea levels and tubular necrosis scores were not reduced by
CR when combined with MK886 injection. Moreover, TNF-α
mRNA levels and Bax/Bcl-2 ratios were not diminished. Here,
we demonstrated that PPAR-α participates in the mechanism
by which CR protects against cisplatin-induced acute kidney
injury, connecting the effect of CR in PPAR-α activation and its
mechanism as a protector to mitigate cisplatin-induced renal
injury.
The data collected here show for the first time that both
CR and physical exercise attenuate the nephrotoxicity caused
by cisplatin injection, but CR shows a better response by
modulating PPAR-α activation. Moreover, we showed that part
of the CR benefit depends on PPAR-α. Further studies are
necessary, but we suggest that CRmight be a good tool to prevent
the nephrotoxicity induced by cisplatin during chemotherapy
treatment.
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